Hye Jin Kang

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

Se Hoon Park, Heung-Moon Chang, Jun Suk Kim et al. · The Lancet Oncology · 2011 · 483 citations

Medicine, Oncology, Pharmacology +9

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

Y-K. Kang, Hye Jin Kang, Dae Young Zang et al. · British Journal of Cancer · 2008 · 136 citations · Full text

Medicine, Oncology, Pharmacology +15

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer

Chul Kim, Jae‐Lyun Lee, Min‐Hee Ryu et al. · Investigational New Drugs · 2009 · 82 citations

Medicine, Oncology, Pharmacology +16

EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil

Im Il Na, Hye Jin Kang, Soo Youn Cho et al. · European Journal of Cancer · 2007 · 79 citations

Medicine, Molecular Genetics, Oncology +10

<i>Chlamydia psittaci</i> infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea

Changhoon Yoo, Min‐Hee Ryu, Jooryung Huh et al. · American Journal of Hematology · 2007 · 70 citations · Full text

Medicine, Infectious Diseases, Pathology +11